Stuart A. Scott

Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach

G. Ruaño, Kyle Melin, J. Duconge, 2021, Clinical and translational science.

Re-envisioning community genetics: community empowerment in preventive genomics

J. Witte, E. Ashley, Jackie Osborne, 2023, Journal of Community Genetics.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

K. Sangkuhl, T. Klein, G. Ruaño, 2023, Clinical pharmacology and therapeutics.

Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy

J. Patel, J. K. Hicks, D. Hertz, 2023, Clinical pharmacology and therapeutics.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy

Julia M. Barbarino, T. Klein, H. McLeod, 2017, Clinical pharmacology and therapeutics.

Clinical Pharmacogenomic MT‐RNR1 Screening for Aminoglycoside‐Induced Ototoxicity and the Post‐Test Counseling Conundrum

L. Edelmann, R. Kornreich, Robert Rigobello, 2023, Clinical pharmacology and therapeutics.

Multi-ethnic genome-wide association study for atrial fibrillation

Jay A. Montgomery, Nathan A. Bihlmeyer, Henry J. Lin, 2018, Nature Genetics.

Aldy 4: An efficient genotyper and star-allele caller for pharmacogenomics

S. C. Sahinalp, Ibrahim Numanagić, Ananth Hari, 2022, bioRxiv.